Zymeworks, Inc. (ZYME)
Zymeworks Market Cap : 1.713B for Feb. 20, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Regeneron Pharmaceuticals, Inc. | 82.43B |
| Vertex Pharmaceuticals, Inc. | 121.15B |
| BioLife Solutions, Inc. | 1.112B |
| ACADIA Pharmaceuticals, Inc. | 4.059B |
| Alnylam Pharmaceuticals, Inc. | 44.59B |
Market Cap Related Metrics
| PS Ratio | 12.80 |
| Price to Book Value | 5.352 |
| Price | 22.72 |
| Earnings Yield | -3.73% |